Page last updated: 2024-10-29

ketoconazole and Atrophy

ketoconazole has been researched along with Atrophy in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
" The aetiology of the atrophy is still unknown, and two main hypotheses have been formulated, one suggesting a correlation with long-term use of topical steroids and the other a delayed type hypersensitivity to epicutaneous antigens derived from components of the fungus."1.46Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome. ( Alaibac, M; Marinello, E; Piaserico, S, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Posada, C1
Batalla, A1
De La Torre, C1
Marinello, E1
Piaserico, S1
Alaibac, M1

Other Studies

2 other studies available for ketoconazole and Atrophy

ArticleYear
Atrophic plaques on the back.
    Cutis, 2014, Volume: 94, Issue:4

    Topics: Administration, Topical; Adult; Antifungal Agents; Atrophy; Back; Biopsy; Diagnosis, Differential; F

2014
Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome.
    BMJ case reports, 2017, Jan-18, Volume: 2017

    Topics: Administration, Cutaneous; Adult; Antifungal Agents; Atrophy; Female; Humans; Ketoconazole; Sjogren'

2017